Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Formoterol fumarate |
Is a |
False |
Formoterol (substance) |
Inferred relationship |
Some |
|
Product containing budesonide and formoterol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Formoterol (substance) |
Inferred relationship |
Some |
2 |
budesonid 80 µg + formoterol 4,5 µg tørpulverinhalator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Formoterol (substance) |
Inferred relationship |
Some |
|
budesonid 160 µg + formoterol 4,5 µg tørpulverinhalator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Formoterol (substance) |
Inferred relationship |
Some |
|
budesonid 320 µg + formoterol 9 µg tørpulverinhalator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Formoterol (substance) |
Inferred relationship |
Some |
|
Product containing formoterol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Formoterol (substance) |
Inferred relationship |
Some |
1 |
Budesonide+eformoterol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Formoterol (substance) |
Inferred relationship |
Some |
|
budesonid 200 µg + formoterolfumarat 6 µg indåndingsudløst tørpulverinhalator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Formoterol (substance) |
Inferred relationship |
Some |
|
budesonid+eformoterolfumarat 100/6 µg indåndingsudløst tørpulverinhalator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Formoterol (substance) |
Inferred relationship |
Some |
|
budesonid 400 µg + formoterolfumarat-dihydrat 12 µg indåndingsudløst tørpulverinhalator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Formoterol (substance) |
Inferred relationship |
Some |
|
formoterol 20 µg, inhalationsvæske, opløsning, hætteglas a 2 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Formoterol (substance) |
Inferred relationship |
Some |
|
Product containing formoterol and mometasone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Formoterol (substance) |
Inferred relationship |
Some |
2 |
Product containing formoterol and glycopyrronium bromide |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Formoterol (substance) |
Inferred relationship |
Some |
|
Product containing formoterol and glycopyrronium bromide in respiratory dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Formoterol (substance) |
Inferred relationship |
Some |
|
Formoterol fumarate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Formoterol (substance) |
Inferred relationship |
Some |
|
Product containing formoterol in pulmonary dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Formoterol (substance) |
Inferred relationship |
Some |
1 |
Product containing budesonide and formoterol in pulmonary dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Formoterol (substance) |
Inferred relationship |
Some |
2 |
Budesonide and formoterol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Formoterol (substance) |
Inferred relationship |
Some |
2 |
Product containing only formoterol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Formoterol (substance) |
Inferred relationship |
Some |
1 |
Product containing only formoterol and mometasone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Formoterol (substance) |
Inferred relationship |
Some |
2 |
Formoterol only product in pulmonary dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Formoterol (substance) |
Inferred relationship |
Some |
1 |
Budesonide and formoterol only product in pulmonary dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Formoterol (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely budesonide 160 microgram and formoterol 4.5 microgram/1 actuation conventional release powder for inhalation (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Formoterol (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely budesonide 160 microgram and formoterol 4.5 microgram/1 actuation conventional release powder for inhalation (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Formoterol (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely budesonide 80 microgram and formoterol 4.5 microgram/1 actuation conventional release powder for inhalation (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Formoterol (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely budesonide 80 microgram and formoterol 4.5 microgram/1 actuation conventional release powder for inhalation (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Formoterol (substance) |
Inferred relationship |
Some |
2 |
Product containing aclidinium and formoterol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Formoterol (substance) |
Inferred relationship |
Some |
1 |
Product containing only aclidinium and formoterol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Formoterol (substance) |
Inferred relationship |
Some |
1 |
Aclidinium- and formoterol-containing product in pulmonary dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Formoterol (substance) |
Inferred relationship |
Some |
1 |
Aclidinium and formoterol only product in pulmonary dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Formoterol (substance) |
Inferred relationship |
Some |
1 |
Product containing only formoterol and tiotropium in pulmonary dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Formoterol (substance) |
Inferred relationship |
Some |
2 |
Formoterol and tiotropium only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Formoterol (substance) |
Inferred relationship |
Some |
2 |
Formoterol- and tiotropium-containing product in pulmonary dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Formoterol (substance) |
Inferred relationship |
Some |
2 |
Formoterol- and tiotropium-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Formoterol (substance) |
Inferred relationship |
Some |
2 |
Ciclesonide- and formoterol- and tiotropium-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Formoterol (substance) |
Inferred relationship |
Some |
2 |
Ciclesonide- and formoterol- and tiotropium-containing product in pulmonary dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Formoterol (substance) |
Inferred relationship |
Some |
2 |
Product containing only ciclesonide and formoterol and tiotropium in pulmonary dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Formoterol (substance) |
Inferred relationship |
Some |
2 |
Product containing only ciclesonide and formoterol and tiotropium (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Formoterol (substance) |
Inferred relationship |
Some |
2 |
Fluticasone and formoterol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Formoterol (substance) |
Inferred relationship |
Some |
2 |
Fluticasone- and formoterol-containing product in pulmonary dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Formoterol (substance) |
Inferred relationship |
Some |
2 |
Fluticasone- and formoterol-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Formoterol (substance) |
Inferred relationship |
Some |
2 |
Fluticasone and formoterol only product in pulmonary dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Formoterol (substance) |
Inferred relationship |
Some |
2 |